Filing Details

Accession Number:
0001012975-17-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-31 16:16:40
Reporting Period:
2017-01-31
Filing Date:
2017-01-31
Accepted Time:
2017-01-31 16:16:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1370053 Anaptysbio Inc ANAB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1018534 D Alan Frazier 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1341169 Frazier Healthcare V, Lp 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1344203 J Nader Naini 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1346944 Fhm V, Llc 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1346948 Fhm V, Lp 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1365617 J Patrick Heron 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1531105 R Nathan Every 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-31 1,428,571 $0.00 1,428,571 No 4 C Direct
Common Stock Acquisiton 2017-01-31 604,055 $0.00 604,055 No 4 C Direct
Common Stock Acquisiton 2017-01-31 195,751 $0.00 195,751 No 4 C Direct
Common Stock Acquisiton 2017-01-31 733,740 $0.00 733,740 No 4 C Indirect See footnote
Common Stock Acquisiton 2017-01-31 209,095 $0.00 209,095 No 4 C Indirect See footnote
Common Stock Acquisiton 2017-01-31 311,291 $15.00 311,291 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-01-31 88,709 $15.00 88,709 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2017-01-31 1,428,571 $0.00 1,428,571 $0.00
Common Stock Series C Preferred Stock Disposition 2017-01-31 604,055 $0.00 604,055 $0.00
Common Stock Series C-1 Preferred Stock Disposition 2017-01-31 195,751 $0.00 195,751 $0.00
Common Stock Series D Preferred Stock Disposition 2017-01-31 733,740 $0.00 733,740 $0.00
Common Stock Series D Preferred Stock Disposition 2017-01-31 209,095 $0.00 209,095 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.
  2. The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.
  3. The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.
  4. The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.
  5. Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
  6. Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
  7. Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.